Skip to main content

Table 1 Comparison of baseline characteristics

From: Relationship among atrial fibrillation, the CHA2DS2-VASc score and ischaemic stroke in patients with coronary artery disease: a propensity score matching study in Hebei, China

 

Before PSM

After PSM

Without stroke (n = 1997)

With stroke (n = 338)

P value

Without stroke (n = 1348)

With stroke (n = 337)

P value

Sex

  

0.771

  

0.980

Female

828 (41.46%)

143 (42.31%)

 

573 (42.51%)

143 (42.43%)

 

Male

1169 (58.54%)

195 (57.69%)

 

775 (57.49%)

194 (57.57%)

 

Age (years)

63.00 (55.00–69.00)

65.00 (60.00–72.00)

< 0.001*

64.00 (58.00–70.00)

65.00 (60.00–72.00)

< 0.001*

BMI (kg/m2)

25.39 (23.44–27.68)

25.50 (23.23–27.68)

0.929

25.39 (23.29–27.68)

25.50 (23.23–27.68)

0.941

CAD type

      

SCAD

128 (6.41%)

36 (10.65%)

0.005*

86 (6.38%)

36 (10.68%)

0.006*

UA

1471 (73.66%)

229 (67.75%)

0.024*

989 (73.37%)

229 (67.95%)

0.047*

NSTEMI

286 (14.32%)

41 (12.13%)

0.283

201 (14.91%)

41 (12.17%)

0.199

STEMI

79 (3.96%)

23 (6.80%)

0.018*

51 (3.78%)

22 (6.53%)

0.027*

Previous MI

205 (10.27%)

49 (14.50%)

0.021*

146 (10.83%)

49 (14.54%)

0.057

Ischaemic cardiomyopathy

34 (1.70%)

11 (3.25%)

0.082

23 (1.71%)

11 (3.26%)

0.069

Heart failure

312 (15.62%)

72 (21.30%)

0.009*

228 (16.91%)

72 (21.36%)

0.056

Hypertension

1307 (65.45%)

262 (77.51%)

< 0.001*

899 (66.69%)

262 (77.74%)

< 0.001*

Dyslipidaemia

605 (30.30%)

95 (28.11%)

0.417

414 (30.71%)

94 (27.89%)

0.313

Total cholesterol (mmol/L)

3.99 (3.40–4.67)

3.94 (3.32–4.76)

0.544

4.00 (3.37–4.68)

3.94 (3.32–4.76)

0.478

LDL-C (mmol/L)

2.51 (1.92–3.11)

2.45 (1.91–3.15)

0.615

2.51 (1.90–3.11)

2.45 (1.91–3.15)

0.567

Valvular heart disease

43 (2.15%)

8 (2.37%)

0.840

32 (2.37%)

8 (2.37%)

1

AF

176 (8.81%)

48 (14.20%)

0.002*

119 (8.83%)

48 (14.24%)

0.003*

AF type

  

 < 0.001*

  

0.003*

No

1821 (91.19%)

290 (85.80%)

 

1229 (91.17%)

289 (85.76%)

 

paroxysmal AF

106 (5.31%)

22 (6.51%)

 

69 (5.12%)

22 (6.53%)

 

Non-paroxysmal AF

70 (3.51%)

26 (7.69%)

 

50 (3.71%)

26 (7.72%)

 

DM

551 (27.59%)

102 (30.18%)

0.327

378 (28.04%)

102 (30.27%)

0.418

COPD

40 (2.00%)

7 (2.07%)

0.836

30 (2.23%)

7 (2.08%)

0.868

CKD

39 (1.95%)

13 (3.85%)

0.043*

23 (1.71%)

13 (3.86%)

0.015*

Creatine (μmol/L)

69.00 (59.00–80.95)

72.00 (61.30–86.00)

0.001*

70.00 (59.00–82.00)

72.00 (61.30–86.00)

0.011*

Fatty liver

39 (1.95%)

5 (1.48%)

0.670

30 (2.23%)

5 (1.48%)

0.393

Smoking

409 (20.48%)

57 (16.86%)

0.124

261 (19.36%)

56 (16.62%)

0.249

Alcohol consumption

347 (17.38%)

47 (13.91%)

0.115

224 (16.62%)

46 (13.65%)

0.184

Aortic atherosclerosis

529 (26.81%)

146 (43.84%)

< 0.001*

386 (28.94%)

146 (43.98%)

< 0.001*

LA (mm)

34.00 (32.00–37.00)

35.00 (32.00–37.00)

0.073

34.00 (32.00–37.00)

35.00 (32.00–37.00)

0.024*

EF (%)

61.74 (60.61–62.89)

61.70 (60.64–62.77)

0.574

61.74 (60.61–62.86)

61.70 (60.64–62.77)

0.73

PWV (cm/s)

1556.50 (1367.50–1798.50)

1623.00 (1418.00–1906.50)

< 0.001*

1575.25 (1388.00–1814.38)

1625.00 (1418.00–1908.62)

0.022*

ABI

1.09 (1.02–1.156)

1.08 (0.97–1.16)

0.057

1.08 (1.01–1.16)

1.08 (0.97–1.16)

0.005*

CHA2DS2-VASc score

3.00 (2.00–4.00)

4.00 (3.00–5.00)

< 0.001*

3.00 (2.00–4.00)

4.00 (3.00–5.00)

< 0.001*

Propensity score

0.16 ± 0.04

0.14 ± 0.04

< 0.001*

0.16 ± 0.04

0.15 ± 0.04

< 0.001*

  1. *Indicates p < 0.05
  2. BMI body mass index, CAD coronary artery disease, SCAD stable coronary artery disease, UA unstable angina, NSTEMI non-ST-elevation myocardial infarction, STEMI ST-elevation myocardial infarction, previous MI previous myocardial infarction, AF atrial fibrillation, DM diabetes mellitus, COPD chronic obstructive pulmonary disease, CKD chronic kidney disease, LDL-C low-density lipoprotein cholesterol, LA left atrial diameter, EF ejection fraction, PWV pulse wave velocity, ABI ankle-brachial index
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us